Mathis, Thibaud http://orcid.org/0000-0002-1418-1872
Holz, Frank G. http://orcid.org/0000-0001-8019-9272
Sivaprasad, Sobha http://orcid.org/0000-0001-8952-0659
Yoon, Young Hee http://orcid.org/0000-0002-2849-7528
Eter, Nicole
Chen, Lee-Jen
Koh, Adrian
Cunha de Souza, Eduardo
Staurenghi, Giovanni
Funding for this research was provided by:
Bayer
Article History
Received: 2 June 2022
Revised: 24 July 2022
Accepted: 30 August 2022
First Online: 14 September 2022
Competing interests
: TM has served as a consultant for AbbVie, Bayer, GSK, Horus and Novartis, and received research grants from Novartis. FGH has served as a consultant for Acucela, Apellis, Bayer, Bioeq/Formycon, Boehringer Ingelheim, Geuder, Graybug, Gyroscope, Heidelberg Engineering, Iveric Bio, Kanghong, Lin BioScience, Novartis, Oxurion, Pixium Vision, Roche/Genentech, Stealth BioTherapeutics and Zeiss, and has received lecture fees from Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, CenterVue, Ellex, Geuder, Heidelberg Engineering, Iveric Bio, Kanghong, NightstaRx, Novartis, Optos, Pixium Vision, Roche/Genentech and Zeiss. SS is the Editor in Chief of <i>Eye</i> at the time of publication, has served a consultant for Bayer, Boehringer Ingelheim, Novartis, Oxurion and Roche, and has received lecture fees from Allergan, Apellis, Bayer, Boehringer Ingelheim, Novartis, Oxurion and Roche. YHY has served as a consultant for Alcon, Allergan, Bayer, Roche and Samsung Bioepis, received research grants from Allergan, Bayer, Novartis, Roche and Samsung Bioepis, and received lecture fees from Alcon, Allergan, Bayer and Roche. NE has served as a consultant for Bayer, Novartis and Roche, received research grants from Bayer and Novartis, and received lecture fees from Allergan, Apellis, Bayer, Novartis and Roche. LJC has served as a consultant for Bayer and Novartis, and has received lecture fees from Bayer and Novartis. AK has served as a consultant for Bayer. ECS has nothing to declare. GS has served as a consultant for Allergan, Apellis, Bayer, Boehringer Ingelheim, CenterVue, Chengdu Kanghong Biotechnology Co., Genentech, Heidelberg Engineering, Kyoto Drug Discovery & Development Co., Novartis and Roche, has received grant fees from Canon, Carl Zeiss Meditec, CenterVue, Heidelberg Engineering, Nidek, Optos, Optovue, Quantel Medical and Topcon, has received lecture fees from Bayer, Heidelberg Engineering, Nidek, Novartis and Roche, and has an Ocular Instrument patent.